SCHEMBL18106954

SCHEMBL18106954

CS(=O)(=O)c1nnc2c(n1)CCCC2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
ALDH1A1 P00352 3/20 0.43
TP53 P04637 2/20 0.43
KDM4E B2RXH2 1/20 0.43
APAF1 O14727 1/20 0.43
NSD2 O96028 1/20 0.43
MAPT P10636 1/20 0.43
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CA12 O43570 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
LMNA P02545 2/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1991256 0.71 SMN1; SMN2 (0.61) L3MBTL1SMN1; SMN2ALDH1A1TP53KDM4E
SCHEMBL11277506 0.69 SMN1; SMN2 (0.59) L3MBTL1SMN1; SMN2ALDH1A1TP53KDM4E
SCHEMBL9955648 0.69 SMN1; SMN2 (0.44) L3MBTL1SMN1; SMN2ALDH1A1TP53MAPT
SCHEMBL7753780 0.68 LMNA (0.52) L3MBTL1SMN1; SMN2ALDH1A1TP53KDM4E
SCHEMBL1992191 0.67 SMN1; SMN2 (0.57) L3MBTL1SMN1; SMN2ALDH1A1TP53KDM4E
SCHEMBL1067810 0.66 SMN1; SMN2 (0.55) L3MBTL1SMN1; SMN2ALDH1A1TP53KDM4E
SCHEMBL7386390 0.66 SMN1; SMN2 (0.41) L3MBTL1SMN1; SMN2ALDH1A1TP53MAPT
SCHEMBL1070289 0.66 SMN1; SMN2 (0.55) L3MBTL1SMN1; SMN2ALDH1A1TP53KDM4E
SCHEMBL11261641 0.66 CA12 (0.50) SMN1; SMN2ALDH1A1KDM4ECA12CA2
SCHEMBL6238026 0.66 KDM4E (0.52) L3MBTL1ALDH1A1TP53KDM4EAPAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2560963-B1 PYRAZINE DERIVATIVES AS INHIBITORS OF THE ENZYME SCD-1 FOR THE TREATMENT OF CANCER DISEASES AND DIABETES PF MEDICAMENT (FR) 2016-10-05 EP disclosed